These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 33123160

  • 21. [Schnitzler syndrome].
    Gellrich FF, Günther C.
    Hautarzt; 2018 Sep; 69(9):761-772. PubMed ID: 30167710
    [Abstract] [Full Text] [Related]

  • 22. A Man With Recurrent Fever, Episodic Rash, and Pain.
    Aslam F, Wiedmeier JE, DiCaudo DJ.
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1106-1113. PubMed ID: 31961498
    [No Abstract] [Full Text] [Related]

  • 23. A case of Schnitzler's syndrome without monoclonal gammopathy successfully treated with canakinumab.
    Fujita Y, Asano T, Sakai A, Norikawa N, Yamamoto T, Matsumoto H, Sato S, Temmoku J, Yashiro-Furuya M, Matsuoka N, Watanabe H, Migita K.
    BMC Musculoskelet Disord; 2021 Mar 08; 22(1):257. PubMed ID: 33685423
    [Abstract] [Full Text] [Related]

  • 24. Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.
    Matsuda T, Takimoto-Ito R, Lipsker D, Kambe N.
    Allergol Int; 2023 Jul 08; 72(3):385-393. PubMed ID: 36906447
    [Abstract] [Full Text] [Related]

  • 25. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
    Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A.
    J Allergy Clin Immunol; 2008 Jan 08; 121(1):260-2. PubMed ID: 17936890
    [No Abstract] [Full Text] [Related]

  • 26. [Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].
    Adam Z, Krejcí M, Pour L, Hájek R.
    Vnitr Lek; 2009 Dec 08; 55(12):1196-7. PubMed ID: 20070037
    [No Abstract] [Full Text] [Related]

  • 27. Remission of Schnitzler syndrome after treatment with anakinra.
    Frischmeyer-Guerrerio PA, Rachamalla R, Saini SS.
    Ann Allergy Asthma Immunol; 2008 Jun 08; 100(6):617-9. PubMed ID: 18592830
    [No Abstract] [Full Text] [Related]

  • 28. An unusual presentation of immunoglobulin A gammopathy in a patient with Schnitzler's syndrome.
    Kaganov E, Jhaveri D, Peters P, IJdo JW.
    Int J Rheum Dis; 2023 Oct 08; 26(10):2085-2088. PubMed ID: 37191194
    [Abstract] [Full Text] [Related]

  • 29. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature.
    Tinazzi E, Puccetti A, Patuzzo G, Sorleto M, Barbieri A, Lunardi C.
    Autoimmun Rev; 2011 May 08; 10(7):404-9. PubMed ID: 21256251
    [Abstract] [Full Text] [Related]

  • 30. Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation.
    Larocca CA, McEvoy JW, Ellis CL, Junkins-Hopkins J, Kolb T, Baer AN, Garibaldi BT.
    Clin Rheumatol; 2012 Jan 08; 31(1):169-74. PubMed ID: 21710158
    [Abstract] [Full Text] [Related]

  • 31. Successful anakinra therapy in 2 patients with Schnitzler syndrome.
    Szturz P, Adam Z, Hájek R, Mayer J.
    Onkologie; 2011 Jan 08; 34(5):265-8. PubMed ID: 21577034
    [No Abstract] [Full Text] [Related]

  • 32. Schnitzler syndrome: treatment failure to rituximab but response to anakinra.
    Eiling E, Möller M, Kreiselmaier I, Brasch J, Schwarz T.
    J Am Acad Dermatol; 2007 Aug 08; 57(2):361-4. PubMed ID: 17467852
    [Abstract] [Full Text] [Related]

  • 33. Cytokines and soluble receptors of the interleukin-1 family in Schnitzler syndrome.
    Migliorini P, Italiani P, Pratesi F, Puxeddu I, Boraschi D.
    Scand J Rheumatol; 2019 May 08; 48(3):235-238. PubMed ID: 30668200
    [Abstract] [Full Text] [Related]

  • 34. Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.
    Salugina SO, Torgashina AV, Borzova EY, Rameev VV, Gorodetsky VR, Fedorov ES, Muravyova NV.
    Dokl Biochem Biophys; 2024 Aug 08; 517(1):214-227. PubMed ID: 38861148
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study.
    Krause K, Weller K, Stefaniak R, Wittkowski H, Altrichter S, Siebenhaar F, Zuberbier T, Maurer M.
    Allergy; 2012 Jul 08; 67(7):943-50. PubMed ID: 22583335
    [Abstract] [Full Text] [Related]

  • 36. [Schnitzler syndrome: diagnostics and treatment].
    Szturz P, Adam Z, Sedivá A, Fojtík Z, Corbová D, Neubauer J, Prásek J, Hájek R, Mayer J.
    Klin Onkol; 2011 Jul 08; 24(4):271-7. PubMed ID: 21905617
    [Abstract] [Full Text] [Related]

  • 37. Occurrence of Rheumatoid Arthritis in a Patient Treated with Anakinra for Schnitzler Syndrome: A Case Report.
    Margerin F, Gottenberg JE, Lipsker D.
    J Rheumatol; 2016 Jul 08; 43(7):1447. PubMed ID: 27371651
    [No Abstract] [Full Text] [Related]

  • 38. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.
    Volz T, Wölbing F, Fischer J, Braun M, Maggoschitz I, Schaller M, Berneburg M, Biedermann T.
    Acta Derm Venereol; 2012 Jul 08; 92(4):393-4. PubMed ID: 22334118
    [No Abstract] [Full Text] [Related]

  • 39. Schnitzler syndrome and Schnitzler-like syndromes.
    Chu CQ.
    Chin Med J (Engl); 2022 May 20; 135(10):1190-1202. PubMed ID: 35089885
    [Abstract] [Full Text] [Related]

  • 40. A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra.
    Ahn MJ, Yu JE, Jeong J, Sim DW, Koh YI.
    Yonsei Med J; 2018 Jan 20; 59(1):154-157. PubMed ID: 29214791
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.